Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-31

Clinical Trial Update: Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether a transdermal nicotine patch improves motor symptoms in advanced Parkinson's disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Idiopathic Parkinson's Disease | Phase 2 | Status: COMPLETED